A recently published study explores the possible benefits to discontinuing an alpha-1 blocker after receiving combination therapy with a 5-alpha reductase inhibitor for the treatment of benign prostatic hyperplasia (BPH). In more symptomatic patients, or patients with confirmed, enlarged prostates, it is recommended to use both medication classes (alpha-1 blocker and 5-alpha reductase inhibitor) to minimize symptoms by relaxing the prostatic smooth muscle and reducing the size of the prostate – producing a potentially synergistic effect. This study found that withdrawal of alpha 1-blockers after a year of combination therapy did not worsen urinary symptoms, QOL, and voiding or storage function. This provides evidence that combination therapy may not be needed indefinitely for all patients.
Guest Authors: Erica Crannage, PharmD and Stephanie Crist, PharmD
Music by Good Talk
Semaglutide for CKD – Does the FLOW trial impact the standard of care?
“We’ed” Better Work Together to Address Cannabis Use in Pregnancy
Remote Patient Monitoring (RPM): The Promise and Pitfalls
An Age-Old Question: Warfarin or a Direct Oral Anticoagulant in Frail Adults?
Complex Patient Case 6: Multiple Comorbidities and Too Many Meds
Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs
Managing COPD: 2024 GOLD Guideline Updates and More
Conquering Confusion: Could Metformin Reduce Dementia Risk?
Complex Patient Case 5: Hypoglycemia and a Painful, Swollen Leg
Top Ten Things Every Clinician Should Know About Pharmacogenomics
Driving + Older Adult + Medications = An Accident Waiting to Happen?
Eosinophils Take the Wheel in Steering Steroid Therapy for COPD Exacerbations
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive